Medicare Enrolled
Dr. Elizabeth Chambers, M.D.
Neurology · Dallas, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Chambers from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chambers? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Chambers
Dr. Elizabeth Chambers is a neurology in Dallas, TX, with 12 years in practice. Based on federal Medicare data, Dr. Chambers performed 30,569 Medicare services across 1,943 unique beneficiaries.
Between the years covered by Open Payments, Dr. Chambers received a total of $18,460 from 64 pharmaceutical and/or device companies across 551 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Chambers is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 12 years in practice▲ Top 3% volume in TX$ $18,460 industry payments
Medicare Practice Summary
Medicare Utilization ↗30,569
Medicare services
Top 3% in TX for neurology
1,943
Unique beneficiaries
$13
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~2,547 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit | 25,630 | $5 | $7 |
| Neuromuscular re-education therapy, per 15 min | 959 | $23 | $144 |
| Physical therapy exercise, per 15 min | 617 | $19 | $141 |
| Office visit, established patient (30-39 min) | 538 | $93 | $215 |
| Office visit, established patient, complex (40-54 min) | 503 | $134 | $275 |
| Functional activity therapy | 410 | $26 | $123 |
| Manual therapy (hands-on treatment), per 15 min | 306 | $18 | $71 |
| Group therapy session | 216 | $11 | $50 |
| New patient office visit, complex (60-74 min) | 168 | $155 | $535 |
| Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | 99 | $63 | $202 |
| Office visit, established patient (20-29 min) | 97 | $55 | $175 |
| Walking/gait training therapy, per 15 min | 87 | $18 | $147 |
| Therapy procedure for a range of mental processes, each additional 15 minutes | 84 | $17 | $250 |
| Evaluation of neuropsychological test, first hour | 65 | $103 | $325 |
| Administration of psychological or neuropsychological test by technician, first 30 minutes | 65 | $27 | $225 |
| Administration of psychological or neuropsychological test by technician, each additional 30 minutes | 64 | $28 | $225 |
| New patient office visit (45-59 min) | 61 | $109 | $425 |
| Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | 53 | $153 | $511 |
| Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, first extremity | 53 | $115 | $551 |
| Treatment of speech, language, voice, communication, and/or hearing processing disorder | 53 | $56 | $225 |
| Evaluation for physical therapy, typically 30 minutes | 50 | $80 | $225 |
| Chronic care management, first 20 min/month | 47 | $48 | $225 |
| Therapy procedure for a range of mental processes, initial 15 minutes | 39 | $18 | $250 |
| Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, each additional extremity | 38 | $74 | $470 |
| Injection of chemical for paralysis of nerve muscles on side of face | 33 | $111 | $491 |
| Punch biopsy, each additional skin growth | 32 | $48 | $85 |
| Hospital follow-up visit, moderate complexity | 32 | $63 | $175 |
| Initial hospital admission, high complexity | 28 | $138 | $300 |
| Hospital follow-up visit, high complexity | 23 | $95 | $256 |
| Mri scan of brain without contrast | 22 | $104 | $879 |
| Office visit, established patient (10-19 min) | 20 | $43 | $120 |
| Chronic care management, additional 20 min/month | 19 | $35 | $75 |
| Test to assess the ability to complete specific functional tasks applicable to environment | 18 | $65 | $178 |
| Punch biopsy, first skin growth | 16 | $84 | $190 |
| Evaluation of neuropsychological test, each additional hour | 13 | $79 | $325 |
| Critical care, first 30-74 min | 11 | $165 | $820 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$18,460
Total received (2018-2024)
Avg $2,637/year across 7 years
Top 17% in TX for neurology
64
Companies
551
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,037 (65.2%)
Scientific / Research
Research funding and grants
$6,423 (34.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$2,637
2023$2,401
2022$2,606
2021$1,607
2020$443
2019$1,128
2018$7,638
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Medtronic USA, Inc.
$6,746
BOSTON SCIENTIFIC CORPORATION
$1,537
Boston Scientific Corporation
$874
ABBVIE INC.
$765
AbbVie Inc.
$628
Amneal Pharmaceuticals LLC
$582
UCB, Inc.
$541
Teva Pharmaceuticals USA, Inc.
$442
Abbott Laboratories
$428
Merz Pharmaceuticals, LLC
$321
ARGENX US, INC.
$256
Biogen, Inc.
$253
Lilly USA, LLC
$253
Sunovion Pharmaceuticals Inc.
$244
Novartis Pharmaceuticals Corporation
$237
ACADIA Pharmaceuticals Inc
$236
PFIZER INC.
$231
Neurocrine Biosciences, Inc.
$216
Ipsen Biopharmaceuticals, Inc
$213
Alexion Pharmaceuticals, Inc.
$209
Acorda Therapeutics, Inc
$177
Eisai Inc.
$173
Biohaven Pharmaceutical Holding Company Ltd.
$170
Genentech USA, Inc.
$167
GE HEALTHCARE
$160
AbbVie, Inc.
$146
Avion Pharmaceuticals
$143
Amgen Inc.
$136
SK Life Science, Inc.
$118
Octapharma USA, Inc.
$107
Grifols USA, LLC
$104
Lundbeck LLC
$99
Neurelis, Inc.
$96
Sumitomo Pharma America, Inc.
$90
Celgene Corporation
$90
SCILEX PHARMACEUTICALS INC.
$83
Avanir Pharmaceuticals, Inc.
$83
Kyowa Kirin, Inc.
$79
EMD Serono, Inc.
$74
GENZYME CORPORATION
$72
Alnylam Pharmaceuticals Inc.
$71
EISAI INC.
$64
Marinus Pharmaceuticals, Inc.
$64
Horizon Therapeutics plc
$61
JAZZ PHARMACEUTICALS INC.
$55
Adamas Pharmaceuticals, Inc.
$55
UPSHER-SMITH LABORATORIES LLC
$49
LivaNova USA, Inc.
$47
Allergan, Inc.
$45
Merz North America, Inc.
$42
TG Therapeutics, Inc.
$40
US WorldMeds, LLC
$39
Medtronic, Inc.
$33
AQUESTIVE THERAPEUTICS, INC.
$31
MERZ NORTH AMERICA, INC.
$28
Biohaven Pharmaceuticals, Inc.
$27
Xeris Pharmaceuticals, Inc.
$24
Life Molecular Imaging Ltd
$20
Janssen Pharmaceuticals, Inc
$15
Harmony Biosciences LLC
$15
ANI Pharmaceuticals, Inc.
$15
IMPEL PHARMACEUTICALS INC.
$13
NS Pharma, Inc.
$13
Greenwich Biosciences, Inc.
$12
Top 3 companies account for 49.6% of total payments
Associated products mentioned in payments ›
ACTIVA · ACTIVA PC · ADUHELM · AJOVY · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · Aimovig · Austedo XR · BOTOX · BRIUMVI · Briviact · COMIRNATY · CONFIRM RX · CREXONT · DUOPA · DYSPORT · Dhivy · Duopa · Dysport · EMGALITY · EPIDIOLEX · Enspryng · Epidiolex · Fintepla · Fycompa · GENERAL DBS · GENERAL DBS · GOCOVRI · GVOKE PFS · Gamunex-C · General - DBS · INBRIJA · INFINITY · INGREZZA · Infinity DBS Pulse Generators · KESIMPTA · KEVEYIS · KYNMOBI · LEADPOINT · LYRICA · Leqembi · MAVENCLAD · MYOBLOC · Mavenclad · NEURACEQ · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · ONGENTYS 50MG CAPSULES 30 · ONPATTRO · Ongentys · PANZYGA · PAXLOVID · PURIFIED CORTROPHIN GEL · Ponvory · QULIPTA · REXULTI · RYTARY · Rystiggo · SKYCLARYS · SOLIRIS · SYMPAZAN · Skyclarys · Soliris · TECFIDERA · TOSYMRA · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VERCISE · VILTEPSO · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VYALEV · VYEPTI · VYVGART · VYVGART HYTRULO · Vercise · Wakix · WaveWriter Alpha Prime 16 · XEOMIN · Xadago · Xeomin · ZEMBRACE SYMTOUCH · ZEPOSIA · ZTALMY · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (65%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $60 per 100 Medicare services performed
Geographic Context
Neurologys within 10 mi
237
Per 100K population
9.1
County median income
$74,149
Nearest hospital
NEXUS CHILDRENS HOSPITAL DALLAS
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Chambers is a mixed practice specialist, with above-average Medicare volume (top 3% in TX), and high industry engagement (low-engagement, top 17%).
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Chambers experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Chambers performed 25,630 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Chambers receive payments from pharmaceutical companies?
Yes. Dr. Chambers received a total of $18,460 from 64 companies across 551 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Chambers's costs compare to other neurologys in Dallas?
Dr. Chambers's average Medicare payment per service is $13. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Chambers) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologys in Dallas
Browse neurologys in Dallas ranked by procedure volume and transparency data.
Highest volume
Top Neurologys in TX
Neurologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologys in TX
Which TX neurologys receive the most from drug and device companies.
By company
Medtronic USA, Inc. Payments to Doctors
See all physicians who received payments from Medtronic USA, Inc..
By company
BOSTON SCIENTIFIC CORPORATION Payments to Doctors
See all physicians who received payments from BOSTON SCIENTIFIC CORPORATION.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology